Bogol, Anabella .
HRN: 07-21-80 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2026
CEFTRIAXONE 1G (VIAL)
06/04/2026
06/10/2026
IV
2gms
OD
UTI; Cholecystitis
Checking Final Appropriateness
06/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/04/2026
06/10/2026
IV
500mg
Q8
Cholecystitis
Checking Final Appropriateness